Genes expressions subtraction of non-cancerous tissue from smokers and non-smokers with adenocarcinoma of lung, may be used as markers for early detection of lung cancer in smoker Source: Eur Respir J 2006; 28: Suppl. 50, 812s Year: 2006
Airway obstruction and or emphysema shows a different plasma inflammatory response in asymptomatic smokers or ex-smokers participating in a lung cancer screening program Source: Annual Congress 2010 - Lung morbidity on exposure to various agents Year: 2010
Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013
Differences in gene expression profiles in non-small cell lung cancer (NSCLC) and in corresponding healthy lung tissue in smokers and non-smokers Source: Annual Congress 2010 - New mechanisms and markers in human lung cancer Year: 2010
Novel sub-classifications of mast cells in human lungs: differential alterations in smokers and COPD Source: Annual Congress 2007 - Advances in respiratory mechanics Year: 2007
ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19 Source: Eur Respir J, 55 (5) 2000688; 10.1183/13993003.00688-2020 Year: 2020
Analysis of the mucus properties in smokers with lung cancer or extra-pulmonary cancer and non smokers with pulmonary metastasis Source: Eur Respir J 2006; 28: Suppl. 50, 656s Year: 2006
Gene expression profiles in non-small cell lung cancer (NSCLC) and lung tissue in smokers and non-smokers Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009
MUC5AC and MUC5B expression in central airways from non-smokers, smokers with normal lung function and GOLD stage 1 and 2 COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 663s Year: 2006
Angiogenesis in bronchial biopsies of symptomatic smokers with and without lung cancer Source: Annual Congress 2008 - Basic science in asthma and COPD II Year: 2008
Epithelial mesenchymal transition (EMT) related changes in small airways of smokers and patients with COPD Source: Virtual Congress 2021 – Pathogenic progress in airway diseases Year: 2021
Different cytological alterations of bronchial mucosa in 178 smoking and non-smoking patients, suffering from COPD: the importance of endobronchial brushing Source: Annual Congress 2009 - Tobacco, bronchial tubes and the lung Year: 2009
Tumor markers in bronchial secretions and serum in patients with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 76s Year: 2004
Morphological markers of resistance bronchial mucosa of smokers to the development of COPD Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016
CCSP modulates inflammation in bronchial epithelium differentiated ex vivo from bronchial biopsy of COPD patients Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010
Functional correlations between bronchial brush-biopsy composition and proteinases and its inhibitors in sputum in smokers and nonsmokers with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 578s Year: 2006
Effectiveness of a panel of sputum markers in smokers with and without COPD to detect pulmonary progression towards functional impairment Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020
Validation of diagnostic molecular markers in bronchial fluid for lung cancer Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer Year: 2011
Potential diagnostic markers in bronquial fluid of patients with non small cell lung cancer (NSCLC) Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009
Alterations of the soluble proteome of airway epithelial cells in COPD Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013